Seattle Genetics | SGEN - Sales Revenues

Name: Seattle Genetics | SGEN - Sales Revenues
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Seattle,Genetics,SGEN,Sales,Revenues,stock,equity,live,intraday,earnings,share,price,historical data,chart,calendar,dividend,yield,news

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Features Questions? Contact us Already a Member? Login

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us

Please Paste this Code in your Website

width

height

Preview

Seattle Genetics

Seattle Genetics reported $519.72M in Sales Revenues for its fiscal quarter ending in March of 2023.

	Sales		Date
AbbVie ABBV:US	USD 12.23B	2.9B	Mar/2023
Acadia Pharmaceuticals ACAD:US	USD 118.46M	18.03M	Mar/2023
Agios Pharmaceuticals AGIO:US	USD 5.61M	1.3M	Mar/2023
Amgen AMGN:US	USD 6.1B	734M	Mar/2023
Astellas Pharma 4503:JP	JPY 354.25B	47.93B	Mar/2023
Bayer BAYN:GR	EUR 14.39B	2.39B	Mar/2023
Biogen BIIB:US	USD 2.46B	81M	Mar/2023
BioMarin Pharmaceutical BMRN:US	USD 596.42M	58.88M	Mar/2023
Bluebird Bio BLUE:US	USD 2.38M	2.32M	Mar/2023
Bristol-Myers Squibb BMY:US	USD 11.34B	69M	Mar/2023
Celldex Therapeutics CLDX:US	USD 967K	646K	Mar/2023
Daiichi Sankyo 4568:JP	JPY 330.2B	10.28B	Mar/2023
Eisai 4523:JP	JPY 198.2B	10.63B	Mar/2023
Eli Lilly LLY:US	USD 6.96B	341.8M	Mar/2023
Esperion Therapeutics ESPR:US	USD 24.33M	5.51M	Mar/2023
Exelixis EXEL:US	USD 408.79M	15.13M	Mar/2023
Genmab GEN:DC	DKK 2.85B	2.37B	Mar/2023
Gilead Sciences GILD:US	USD 6.35B	1.04B	Mar/2023
GlaxoSmithKline GSK:LN	GBP 6.95B	425M	Mar/2023
Glaxosmithkline GSK:US	GBP 6.95B	425M	Mar/2023
Immunogen IMGN:US	USD 49.87M	8.7M	Mar/2023
Incyte Corp INCY:US	USD 808.67M	118.03M	Mar/2023
Insmed INSM:US	USD 65.21M	5.91M	Mar/2023
Karyopharm Therapeutics KPTI:US	USD 38.7M	5.12M	Mar/2023
MacroGenics MGNX:US	USD 24.5M	48.6M	Mar/2023
Merck & Co MRK:US	USD 14.49B	657M	Mar/2023
Mirati Therapeutics MRTX:US	USD 7.17M	6.23M	Mar/2023
Moderna Inc MRNA:US	USD 1.86B	3.22B	Mar/2023
Nektar Therapeutics NKTR:US	USD 21.59M	429K	Mar/2023
Novartis NOVN:VX	USD 13.21B	207M	Mar/2023
Pfizer PFE:US	USD 18.28B	6.01B	Mar/2023
Puma Biotechnology PBYI:US	USD 52.78M	12.9M	Mar/2023
Regeneron Pharmaceuticals REGN:US	USD 3.16B	252.3M	Mar/2023
Sanofi SAN:FP	EUR 10.22B	503M	Mar/2023
Sarepta Therapeutics SRPT:US	USD 253.5M	4.93M	Mar/2023
Seattle Genetics SGEN:US	USD 519.72M	8.43M	Mar/2023
Spectrum Pharmaceuticals SPPI:US	USD 15.61M	5.5M	Mar/2023
Takeda 4502:JP	JPY 956.16B	140.4B	Mar/2023
Teva Pharmaceutical Industries Ltd TEVA:IT	USD 3.66B	223M	Mar/2023
Vertex Pharmaceuticals VRTX:US	USD 2.37B	72.1M	Mar/2023
Xencor XNCR:US	USD 18.96M	2.65M	Mar/2023